SetLance is a biotech company focused on the development of peptide-based drugs.
It was founded in 2009 by Luisa Bracci, Chiara Falciani and Alessandro Pini, researchers at the University of Siena, Italy.
SetLance has its registered offices at Toscana Life Sciences (TLS) campus in Siena.
The company aims at the development of novel peptide-based drug candidates for the treatment of severe human diseases – with a special focus on bacterial infections and cancer.
The company is also involved in the development of peptide-based medical devices.
June 16th - 18th, 2022 Oral presentations: “Antimicrob...
December 12th, 2020 Oral presentation: "Characterization an...